Cart
sales@molnova.com
D-Threonine
CAS No. 632-20-2
D-Threonine( H-D-Thr-OH )
Catalog No. M28329 CAS No. 632-20-2
D-Threonine is one of the metabolites of Saccharomyces cerevisiae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 29 | In Stock |
|
Biological Information
-
Product NameD-Threonine
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-Threonine is one of the metabolites of Saccharomyces cerevisiae.
-
DescriptionD-Threonine is one of the metabolites of Saccharomyces cerevisiae.
-
In Vitro——
-
In Vivo——
-
SynonymsH-D-Thr-OH
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number632-20-2
-
Formula Weight119.12
-
Molecular FormulaC4H9NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (839.49 mM)
-
SMILESC[C@@H]([C@H](C(O)=O)N)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moya C, et al. Tuning the magnetic properties of Co-ferrite nanoparticles through the 1,2-hexadecanediol concentration in the reaction mixture. Phys Chem Chem Phys. 2015 May 21;17(19):13143-9.
molnova catalog
related products
-
Aflatoxin B1
Aflatoxin B1 (AFB1) is a Group 1A carcinogen and a secondary metabolite produced by Aspergillus flavus and A. parasiticus. Aflatoxin B1 (AFB1) primarily induces mutations by causing a G to T transversion at the third nucleotide of codon 249 in the tumor suppressor gene p53. In the body, Aflatoxin B1 (AFB1) can cause damage to the intestines and kidneys and has some teratogenic effects.
-
Petroselinic acid
Petroselinic acid is a monounsaturated omega-12 fatty acid found naturally in plant and animal oils and fats.
-
PAPA NONOate
PAPA NONOate is a pH-regulated NO donor.PAPA NONOate has potential antitumor activity and can be used to study diabetic wound healing disorders.
